Kirkland Advises KKR on Financing for Recommended Public Offer of Biotage

Kirkland & Ellis is advising RWK Bidco AB, a newly formed company indirectly wholly owned by KKR Funds, on the financing for its recommended public offer to the shareholders of Biotage AB ("Biotage") to tender all ordinary shares in Biotage. The offer values Biotage at approximately SEK 11.607 billion. The completion of the offer is conditional upon, inter alia, receipt of regulatory clearances.

Biotage is a global supplier and solutions partner to a wide range of customers within drug discovery, development and analytical testing.

Read KKR's press release

The Kirkland team includes debt finance lawyers Ian Barratt, Natasha Smith and Luca Misseroni.